Literature DB >> 30592096

Dexmedetomidine protects rats from postoperative cognitive dysfunction via regulating the GABAB R-mediated cAMP-PKA-CREB signaling pathway.

Yun-Sheng Zhu1, Ying-Fen Xiong1, Fo-Quan Luo1, Jia Min1.   

Abstract

This work attempts to discuss whether dexmedetomidine (Dex) can protect rats from postoperative cognitive dysfunction (POCD) through regulating the γ-aminobutyric acid-B receptor (GABAB R)-mediated cyclic adenosine monophosphate (cAMP) - protein kinase A (PKA) - cAMP-response element binding (cAMP-PKA-CREB) signaling pathway. Sprague-Dawley rats were divided into a non-surgical group (Control), a surgical group (Model), a surgical group treated with Dex (Model + Dex), a surgical group treated with GABAB R antagonist (Model + CGP 35348) and a surgical group treated with Dex and GABAB R agonist (Model + Dex + Baclofen). Cognitive and memory functions were evaluated by Y-maze test and open-field test. The neuronal morphology of the hippocampus was observed by hematoxylin and eosin staining and neuronal apoptosis was by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling method. Inflammatory factors and cAMP levels were detected by enzyme-linked immunosorbent assay while expressions of GABAB R and PKA-CREB pathway-related molecules by Western blot. Compared with control rats, the model rats exhibited reduced alternation rates with a prolonged time spent in the central zone; meanwhile, levels of tumor necrosis factor-α and interleukin-1β and the apoptotic index, as well as GABAB R1 and GABAB R2 expressions were increased in the model rats, but the cAMP-PKA-CREB pathway was inhibited (all P < 0.05). When treated with either Dex or CGP 35348, the surgical rats displayed an opposite tendency concerning the above factors as compared to the model rats (all P < 0.05). Furthermore, Baclofen, the agonist of GABAB R, could reverse the protective effect of Dex against POCD in rats. Dex protects rats from POCD possibly via suppressing GABAB R to up-regulate the cAMP-PKA-CREB signaling pathway, thereby alleviating the hippocampal inflammation caused by surgical trauma.
© 2018 Japanese Society of Neuropathology.

Entities:  

Keywords:  GABABR; cAMP-PKA-CREB signaling pathway; dexmedetomidine; postoperative cognitive dysfunction

Mesh:

Substances:

Year:  2018        PMID: 30592096     DOI: 10.1111/neup.12530

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  5 in total

1.  Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction in Aged Mice.

Authors:  Xiaolan Xie; Zhiwen Shen; Chuwen Hu; Kun Zhang; Mingyan Guo; Fei Wang; Kai Qin
Journal:  Neurochem Res       Date:  2021-06-23       Impact factor: 3.996

2.  Dexmedetomidine Attenuates Neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340.

Authors:  Yang Bao; Yijun Zhu; Guangbao He; Hongwei Ni; Chenxia Liu; Limin Ma; Lifeng Zhang; Dongping Shi
Journal:  Drug Des Devel Ther       Date:  2019-10-03       Impact factor: 4.162

3.  The Effects of Dexmedetomidine in a Rat Model of Sepsis-Induced Lung Injury are Mediated Through the Adenosine Monophosphate-Activated Protein Kinase (AMPK)/Silent Information Regulator 1 (SIRT1) Pathway.

Authors:  Ronghui Wang; Yongxiang Xie; Jiwei Qiu; Jueying Chen
Journal:  Med Sci Monit       Date:  2020-02-08

4.  GABAB receptor antagonist promotes hippocampal neurogenesis and facilitates cognitive function recovery following acute cerebral ischemia in mice.

Authors:  Dan Song; Yaohua Chen; Cheng Chen; Lili Chen; Oumei Cheng
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

5.  GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer.

Authors:  Huihui Wang; Hao Zhang; Zhirong Sun; Wankun Chen; Changhong Miao
Journal:  Int J Biol Sci       Date:  2021-05-10       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.